# EDGAR Filing Document

**Accession Number:** 0001810747
**File Stem:** 0000940400-26-021285
**Filing Date:** 2026-5
**Character Count:** 28557
**Document Hash:** fa3f8dad5702c1e178aaad3605122044
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-021285.hdr.sgml**: 20260527

**ACCESSION NUMBER**: 0000940400-26-021285

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260527

**DATE AS OF CHANGE**: 20260527

**PERIOD START**: 20260630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Simplify Exchange Traded Funds
- **CENTRAL INDEX KEY:** 0001810747

**ORGANIZATION NAME:**
- **EIN:** 851887571
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23570
- **FILM NUMBER:** 261023870

**BUSINESS ADDRESS:**
- **STREET 1:** 222 BROADWAY
- **STREET 2:** 22ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10038
- **BUSINESS PHONE:** 646-741-2438

**MAIL ADDRESS:**
- **STREET 1:** 222 BROADWAY
- **STREET 2:** 22ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10038

## Series and Classes Contracts Data

### Simplify Health Care ETF (Series ID: S000073751)

| Class ID   | Class Name               | Ticker Symbol   |
|:---|:---|:---|
| C000230898 | Simplify Health Care ETF | PINK            |

## Nport-Ex

#### Simplify

#### Health

#### Care

#### ETF

#### Schedule

#### of

#### Investments
March

31,

2026

(Unaudited)

#### Shares

#### Value

#### Common

#### Stocks

#### –

#### 98.6%

#### Consumer

#### Discretionary

#### –

#### 2.7%
Warby

Parker,

Inc.,

Class

A\*

..................................................

290,831

$

6,127,809

#### Health

#### Care

#### –

#### 89.1%
10X

Genomics,

Inc.,

Class

A\*

.................................................

353,005

7,494,296

Abbott

Laboratories

.........................................................

15,506

1,592,001

AbbVie,

Inc.

...............................................................

48,621

10,574,581

Abivax

SA,

ADR\*

...........................................................

24,497

agilon

health,

Inc.\*

..........................................................

6,360

50,305

Align

Technology,

Inc.\*

......................................................

106,897

18,325,353

Alignment

Healthcare,

Inc.\*

..................................................

190,995

3,365,332

Amgen,

Inc.

...............................................................

15,844

5,574,711

AstraZeneca

PLC

..........................................................

25,818

5,091,826

Benitec

Biopharma,

Inc.\*

.....................................................

562,242

5,987,877

Biohaven

Ltd.\*

.............................................................

898,400

7,600,464

Boston

Scientific

Corp.\*

.....................................................

11,324

710,581

Bristol-Myers

Squibb

Co.

....................................................

830

50,340

Chugai

Pharmaceutical

Co.

Ltd.

...............................................

225,065

12,211,554

Cooper

Cos.,

Inc.

(The)\*

.....................................................

9,942

710,853

CVS

Health

Corp.

..........................................................

52,456

3,767,390

Cypherpunk

Technologies,

Inc.\*

...............................................

21,139

16,797

Danaher

Corp.

.............................................................

32,304

6,124,838

Edwards

Lifesciences

Corp.\*

.................................................

14,078

1,127,366

Eli

Lilly

&

Co.

..............................................................

16,703

15,362,918

Embecta

Corp.

............................................................

2,210

19,536

Establishment

Labs

Holdings,

Inc.\*

............................................

53,009

3,009,851

EyePoint,

Inc.\*

.............................................................

272,616

3,514,020

Fulcrum

Therapeutics,

Inc.\*

..................................................

115,994

889,674

GE

HealthCare

Technologies,

Inc.

.............................................

39,260

2,794,527

Gilead

Sciences,

Inc.

.......................................................

61,345

8,549,653

Guardant

Health,

Inc.\*

.......................................................

20,821

1,923,236

HealthEquity,

Inc.\*

..........................................................

26,241

ICON

PLC\*

...............................................................

1,139

126,042

Insmed,

Inc.\*

..............................................................

10,217

1,670,684

Intuitive

Surgical,

Inc.\*

.......................................................

10,767

4,963,479

Jazz

Pharmaceuticals

PLC\*

..................................................

51,730

9,779,557

Johnson

&

Johnson

.........................................................

26,820

6,555,881

Neurocrine

Biosciences,

Inc.\*

.................................................

2,505

330,009

Novo

Nordisk

A/S,

ADR

......................................................

327,357

12,030,370

Pacira

BioSciences,

Inc.\*

....................................................

62,653

1,415,958

Praxis

Precision

Medicines,

Inc.\*

..............................................

90,858

Regeneron

Pharmaceuticals,

Inc.

..............................................

10,900

8,421,776

Sarepta

Therapeutics,

Inc.\*

...................................................

5,803

126,273

Stryker

Corp.

..............................................................

1,710

561,889

Syndax

Pharmaceuticals,

Inc.\*

................................................

628

14,670

Teleflex,

Inc.

..............................................................

1,109

132,648

TG

Therapeutics,

Inc.\*

......................................................

16,049

533,148

Thermo

Fisher

Scientific,

Inc.

.................................................

17,409

8,557,046

United

Therapeutics

Corp.\*

...................................................

34,251

20,310,158

UnitedHealth

Group,

Inc.

.....................................................

1,811

490,038

Vertex

Pharmaceuticals,

Inc.\*

.................................................

7,936

3,543,741

#### Simplify

#### Health

#### Care

#### ETF

#### Schedule

#### of

#### Investments
(Continued)

March

31,

2026

(Unaudited)

#### Shares

#### Value

#### Common

#### Stocks
(continued)

#### Health

#### Care
(continued)

Zimmer

Biomet

Holdings,

Inc.

.................................................

3,315

$

299,742

206,444,585

#### Industrials

#### –

#### 2.8%
3M

Co.

...................................................................

43,380

6,300,077

Fluor

Corp.\*

...............................................................

4,703

219,395

Veralto

Corp.

..............................................................

588

51,991

6,571,463

#### Materials

#### –

#### 4.0%
PureCycle

Technologies,

Inc.\*

................................................

1,770,778

9,190,338

Total

Common

Stocks

(Cost

$233,815,936)

..........................................

228,334,195

#### Money

#### Market

#### Fund

#### –

#### 0.4%
Dreyfus

Treasury

Obligations

Cash

Management

Fund,

Institutional

Shares,

3.54%(a)

(Cost

$931,316)

..........................................................

931,316

931,316

Total

Investments

–

99.0%

(Cost

$234,747,252)

............................................................

$

229,265,511

Other

Assets

in

Excess

of

Liabilities

–

1.0%

............................................

2,403,124

#### Net

#### Assets

#### –

#### 100.0%

#### .............................................................

#### $

#### 231,668,635
\*

Non

Income

Producing

(a) Rate

shown

reflects

the

7-day

yield

as

of

March

31,

2026. #### Abbreviations:
ADR

:

American

Depositary

Receipt

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Simplify Exchange Traded Funds

- **b. Investment Company Act file number:** 811-23570

- **c. CIK number of Registrant:** 0001810747

- **d. LEI of Registrant:** 549300LDDEMEUCZQEO55

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 10845 Griffith Peak Drive

  - **City:** Las Vegas

  - **State:** NV

  - **Foreign country:** US

  - **Zip / Postal Code:** 89135

  - **Telephone number:** (702) 389-9705

**Item A.2. Information about the Series.**

- **a. Name of Series:** Simplify Health Care ETF

- **b. EDGAR series identifier (if any):** S000073751

- **c. LEI of Series:** 549300WPEU6YIKEJVH06

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-06-30

- **b. Date as of which information is reported:** 2026-03-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $234344900.43

**Total Liabilities:** $142454.43

**Net Assets:** $234202446.00

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000230898 | -1.31%               | 0.68%                | -7.40%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $2927999.14              | $-7901247.79                               |
| Month 2  | $1065246.85              | $323028.89                                 |
| Month 3  | $2033587.14              | $-23336186.46                              |

### Schedule of Portfolio Investments

| Name                                | Title                                        | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Insmed Inc                          | Insmed Inc COM PAR $.01                      | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     10328 | NS      | $1688834.56   | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                        | Biohaven Ltd COM                             | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | VG        |    908165 | NS      | $7683075.90   | 3.28%             |  |  |  | No            |                  1 | On Loan: No      |
| The Cooper Companies, Inc.          | The Cooper Companies, Inc. COM               | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |     10050 | NS      | $718575.00    | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated COM      | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |      8020 | NS      | $3581250.80   | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc.             | Intuitive Surgical Inc. COM NEW              | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |     10884 | NS      | $5017415.16   | 2.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Healthequity Inc                    | Healthequity Inc COM                         | CUSIP: 42226A107<br>LEI: 529900LRJU1RAFQHM467 | Long             | EC               | CORP              | US        |       317 | NS      | $26491.69     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ESTABLISHMENT LABS HOLDINGS INC     | Establishment Labs Hldgs Inc COM             | CUSIP: 000000000<br>LEI: 549300BCBQ714JNJ7V58 | Long             | EC               | CORP              | VG        |     53585 | NS      | $3042556.30   | 1.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                 | Abbott Laboratories COM                      | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |     15674 | NS      | $1609249.58   | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                     | AstraZeneca PLC ORD USD0.25                  | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     26097 | NS      | $5146850.34   | 2.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc.         | Syndax Pharmaceuticals Inc. COM              | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |       634 | NS      | $14810.24     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Warby Parker Inc                    | Warby Parker Inc CL A COM                    | CUSIP: 93403J106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    293990 | NS      | $6194369.30   | 2.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc            | Sarepta Therapeutics Inc COM                 | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |      5866 | NS      | $127644.16    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| DREYFUS TRSY OBLIG CASH M           | DREYFUS TRSY OBLIG CASH M                    | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    931316 | NS      | $931316.15    | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Alignment Healthcare Inc            | Alignment Healthcare Inc COM                 | CUSIP: 01625V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    193071 | NS      | $3401911.02   | 1.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc.                          | Amgen Inc. COM                               | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     16015 | NS      | $5634877.75   | 2.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc        | Thermo Fisher Scientific Inc COM             | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |     17598 | NS      | $8649944.94   | 3.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corporation                 | Danaher Corporation COM                      | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |     32655 | NS      | $6191388.00   | 2.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.     | Regeneron Pharmaceuticals, Inc. COM          | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     11017 | NS      | $8512174.88   | 3.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Abivax SA                           | Abivax SA SPONSORED ADS                      | CUSIP: 00370M103<br>LEI: 969500D8TMNB184OJU95 | Long             | EC               | CORP              | FR        |       220 | NS      | $24497.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Benitec Biopharma Inc               | Benitec Biopharma Inc COM NEW                | CUSIP: 08205P209<br>LEI: 5493001KMFMXZM1EU014 | Long             | EC               | CORP              | US        |    568353 | NS      | $6052959.45   | 2.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Praxis Precision Medicines Inc      | Praxis Precision Medicines Inc COM NEW       | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       285 | NS      | $91824.15     | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| TG Therapeutics Inc                 | TG Therapeutics Inc COM                      | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |     16223 | NS      | $538928.06    | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira Biosciences Inc              | Pacira Biosciences Inc COM                   | CUSIP: 695127100<br>LEI: 549300P56LERYBDHCF69 | Long             | EC               | CORP              | US        |     63334 | NS      | $1431348.40   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd.       | Chugai Pharmaceutical Co Ltd. NPV            | CUSIP: 000000000<br>LEI: 529900T9LAII161DCN95 | Long             | EC               | CORP              | JP        |    225065 | NS      | $12211554.24  | 5.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Eyepoint Inc.                       | Eyepoint Inc. COM NEW                        | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |    275577 | NS      | $3552187.53   | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Company        | Bristol-Myers Squibb Company COM             | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |       839 | NS      | $50885.35     | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Embecta Corp.                       | Embecta Corp. COMMON STOCK                   | CUSIP: 29082K105<br>LEI: 549300RPG8GXVDHNXZ62 | Long             | EC               | CORP              | US        |      2234 | NS      | $19748.56     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                   | Johnson & Johnson COM                        | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     27111 | NS      | $6627012.84   | 2.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Align Technology Inc.               | Align Technology Inc. COM                    | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |    108058 | NS      | $18524382.94  | 7.91%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corporation     | United Therapeutics Corporation COM          | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     34623 | NS      | $20530746.54  | 8.77%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc.                         | AbbVie Inc. COM                              | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     49149 | NS      | $10689416.01  | 4.56%             |  |  |  | No            |                  1 | On Loan: No      |
| PURECYCLE TECHNOLOGIES INC          | PureCycle Technologies Inc. COM              | CUSIP: 74623V103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1790023 | NS      | $9290219.37   | 3.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC            | Jazz Pharmaceuticals PLC SHS USD             | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     52291 | NS      | $9885613.55   | 4.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc.                | Gilead Sciences Inc. COM                     | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     62011 | NS      | $8642473.07   | 3.69%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                     | CVS Health Corp COM                          | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |     53026 | NS      | $3808327.32   | 1.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc          | Neurocrine Biosciences Inc COM               | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |      2532 | NS      | $333565.68    | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co.                     | Eli Lilly & Co. COM                          | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     16883 | NS      | $15528476.91  | 6.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Veralto Corp.                       | Veralto Corp. COM SHS                        | CUSIP: 92338C103<br>LEI: 635400FJE6GSOJUSNY27 | Long             | EC               | CORP              | US        |       594 | NS      | $52521.48     | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                 | Guardant Health Inc COM                      | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     21046 | NS      | $1944019.02   | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| 3M Company                          | 3M Company COM                               | CUSIP: 88579Y101<br>LEI: LUZQVYP4VS22CLWDAR65 | Long             | EC               | CORP              | US        |     43851 | NS      | $6368480.73   | 2.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilon Health Inc                   | Agilon Health Inc COM NEW                    | CUSIP: 00857U206<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6429 | NS      | $50850.86     | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corporation    | Edwards Lifesciences Corporation COM         | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |     14231 | NS      | $1139618.48   | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| GE Healthcare Technologies Inc.     | GE Healthcare Technologies Inc. COMMON STOCK | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |     39686 | NS      | $2824849.48   | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corporation                 | Stryker Corporation COM                      | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |      1728 | NS      | $567803.52    | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Fulcrum Therapeutics Inc            | Fulcrum Therapeutics Inc COM                 | CUSIP: 359616109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    117254 | NS      | $899338.18    | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc          | Zimmer Biomet Holdings Inc COM               | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |      3351 | NS      | $302997.42    | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Icon PLC                            | Icon PLC SHS                                 | CUSIP: 000000000<br>LEI: 6354008SRQGEMC4XFI67 | Long             | EC               | CORP              | IE        |      1151 | NS      | $127369.66    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                    | Novo Nordisk A/S ADR                         | CUSIP: 670100205<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |    330915 | NS      | $12161126.25  | 5.19%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X Genomics Inc                    | 10X Genomics Inc CL A COM                    | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |    356842 | NS      | $7575755.66   | 3.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Teleflex Incorporated               | Teleflex Incorporated COM                    | CUSIP: 879369106<br>LEI: UUL85LWXB4NGSWWXIQ25 | Long             | EC               | CORP              | US        |      1121 | NS      | $134082.81    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Fluor Corporation                   | Fluor Corporation COM                        | CUSIP: 343412102<br>LEI: CQ7WZ4NOFWT7FAE6Q943 | Long             | EC               | CORP              | US        |      4754 | NS      | $221774.10    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc         | Apellis Pharmaceuticals Inc COM              | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |     57335 | NS      | $2306587.05   | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corporation       | Boston Scientific Corporation COM            | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |     11447 | NS      | $718299.25    | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Cypherpunk Technologies Inc.        | Cypherpunk Technologies Inc. COM NEW         | CUSIP: 52187K200<br>LEI: 549300T31SMMJ2DDLI13 | Long             | EC               | CORP              | US        |     21367 | NS      | $16978.22     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc.             | UnitedHealth Group Inc. COM                  | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |      1829 | NS      | $494909.11    | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-05-27

**Name of Applicant:** Simplify Exchange Traded Funds

**Signature:** Paul Kim

**Name of Signer:** Paul Kim

**Title:** Trustee & President